Free Trial

Skye Bioscience (SKYE) Insider Trading & Ownership

Skye Bioscience logo
$4.95 -0.56 (-10.16%)
(As of 11/15/2024 08:55 PM ET)

Skye Bioscience (NASDAQ:SKYE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.00%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$1.75 M
Get SKYE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Skye Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SKYE Insider Buying and Selling by Quarter

Skye Bioscience Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/13/2024Andrew J SchwabDirectorSell13,837$6.06$83,852.22  
9/11/2024Andrew J SchwabDirectorSell252,500$6.60$1,666,500.00  
(Data available from 1/1/2013 forward)

SKYE Insider Trading Activity - Frequently Asked Questions

The list of insiders at Skye Bioscience includes Andrew J Schwab. Learn more on insiders at SKYE.

3.00% of Skye Bioscience stock is owned by insiders. Learn more on SKYE's insider holdings.

The following insider sold SKYE shares in the last 24 months: Andrew J Schwab ($1,750,352.22).

Insiders have sold a total of 266,337 Skye Bioscience shares in the last 24 months for a total of $1,750,352.22 sold.

Skye Bioscience Key Executives

  • Mr. Punit S. Dhillon B.A. (Age 44)
    Executive Chairman, President, CEO & Secretary
    Compensation: $720k
  • Dr. Christopher G. Twitty Ph.D. (Age 51)
    Chief Scientific Officer
  • Mr. Tu Diep M.Sc. (Age 43)
    Chief Development Officer


This page (NASDAQ:SKYE) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners